Torsion dystonia and spasmodic torticollis—results of treatment with L‐dopa

No abstract is available for this paper.

• Publication year

  1970

• Venue

  Neurology

• Publication date

  1970-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.20.11_Part_2.107PMID 5529472
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DYSTONIA: I. HISTORICAL REVIEW; ANALYSIS OF DYSTONIC SYMPTOMS AND PHYSIOLOGIC MECHANISMS INVOLVED

  1944cited by this paper

• Perspectives on the pharmacological management of dystonia

  2021cites this paper
• How Many Dystonias? Clinical Evidence

  2017cites this paper
• Closed-loop programming: animal studies

  2014cites this paper
• Animal models for dystonia

  2013cites this paper
• Levodopa: A Review of its Pharmacological Properties and Therapeutic Uses with Particular Reference to Parkinsonism

  2012cites this paper
• Medical therapy for dystonia

  2012cites this paper
• The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases

  2011cites this paper
• Convergent mechanisms in etiologically-diverse dystonias

  2011cites this paper
• Treatment strategies for dystonia

  2010cites this paper
• Idiopathic dystonia: Neuropharmacological study

  2004cites this paper
• [Therapeutic possibilities in spasmodic torticollis].

  1991cites this paper
• The Pharmacology of Levodopa in Treatment of Parkinson’s Disease: An Update

  1989cites this paper
• Dystonia with marked diurnal variation associated with biopterin deficiency

  1988cites this paper
• Möglichkeiten und Grenzen der Behandlung mit Neurotransmittern bei neuropädiatrischen Erkrankungen

  1987cites this paper
• Parkinsonism following dystonia in three patients

  1986cites this paper
• Torsion dystonia

  1986cites this paper
• Dopamine agonists in the treatment of dystonia.

  1985cites this paper
• Dystonia: treatment with bromocriptine.

  1985cites this paper
• Overview of Norepinephrine in Selected Pediatric Disorders

  1985cites this paper
• 5‐hydroxytryptamine in platelets of torsion dystonia patients

  1985cites this paper
• Action‐induced rhythmic dystonia

  1984cites this paper
• Spasmodic torticollis and other idiopathic torsion dystonias. Medical management.

  1984cites this paper
• Spasmodic torticollis: A behavioral perspective

  1982cites this paper
• The Focal Dystonias

  1982cites this paper
• Dystonia musculorum deformans: implications of therapeutic response to levodopa and carbamazepine.

  1982cites this paper
• Behavioral Interventions in Pediatric Neurology

  1982cites this paper
• Torsion Dystonia: Clinical Spectrum and Treatment

  1982cites this paper
• Brain involvement in spasmodic torticollis

  1981cites this paper
• Früh-und Spätergebnisse bei 29 operierten Patienten mit Torticollis spasticus

  1980cites this paper
• Dopaminergic systems and speech fluency

  1980cites this paper
• Pathophysiology and Pharmacotherapy of Spasmodic Torticollis: A Review

  1979cites this paper
• Experimental torticollis in the marmoset produced by injection of 6-hydroxydopamine into the ascending nigrostriatal pathway.

  1979cites this paper
• Lithium carbonate: a therapeutic agent for spasmodic torticollis.

  1979cites this paper
• Bromocriptine treatment of spasmodic torticollis. A double-blind crossover study.

  1979cites this paper
• Progressive dystonia with marked diurnal fluctuation

  1978cites this paper
• Diminished ventricular fluid dopamine metabolites in adult‐onset dystonia

  1978cites this paper
• Basic Considerations on the Role of Concertedly Working Dopaminergic, Gaba-Ergic, Cholinergic and Serotonergic Mechanisms within the Neo-Striatum and Nucleus Accumbens in Locomotor Activity, Stereotyped Gnawing, Turning and Dyskinetic Activities

  1977cites this paper
• New approaches in the management of hyperkinetic movement disorders.

  1977cites this paper
• Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data

  1976cites this paper
• L-Dopa and the treatment of extrapyramidal disease.

  1975cites this paper
• Catecholamines and neurologic diseases.

  1975cites this paper
• Catecholamines and neurologic diseases (second of two parts).

  1975cites this paper
• Quantitative measurements in spasmodic torticollis. Description of a method and results of measurement.

  1974cites this paper
• Dystonic symptoms in children. Treatment with carbamazepine.

  1974cites this paper
• Idiopathic torsion dystonia (dystonia musculorum deformans). A review of forty-two patients.

  1974cites this paper
• Spasmodic torticollis: treatment by feedback display of the EMG.

  1974cites this paper
• Clinical significance of probenecid test.

  1973cites this paper
• Intravenous Diazepam in Drug-Induced Dystonic Reactions

  1973cites this paper
• Elevated plasma dopamine-beta-hydroxylase activity in autosomal dominant torsion dystonia.

  1973cites this paper
• Spasmodic torticollis and L‐dopa

  1972cites this paper
• The medical treatment of spasmodic torticollis.

  1972cites this paper
• Medical treatment of spasmodic torticollis.

  1972cites this paper
• [Dystonias].

  1972cites this paper